531210 — Colinz Laboratories Cashflow Statement
0.000.00%
- IN₹136.94m
- IN₹87.85m
- IN₹65.28m
- 58
- 36
- 49
- 46
Annual cashflow statement for Colinz Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2.45 | 4.8 | 6 | 6.5 | 6.19 |
Depreciation | |||||
Non-Cash Items | -0.818 | -0.953 | -0.961 | -2.37 | -2.46 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 18 | -1.19 | -2.3 | 4.91 | -19.6 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 21.6 | 4.67 | 4.03 | 10.3 | -14.5 |
Capital Expenditures | -1.58 | -0.375 | 0 | — | -2.62 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.031 | 0.05 | 0.087 | 0.069 | 0.276 |
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -1.55 | -0.325 | 0.087 | 0.069 | -2.34 |
Financing Cash Flow Items | 0.801 | 0.903 | 1.11 | 2.3 | 2.38 |
Other Financing Cash Flow | |||||
Cash from Financing Activities | 0.801 | 0.903 | 1.11 | 2.3 | 2.38 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 20.8 | 5.25 | 5.23 | 12.7 | -14.5 |